龙沙集团（VTX:LONN）的内在价值可能比其股价低26% - 雅虎财经
Lonza Group AG's (VTX:LONN) Intrinsic Value Is Potentially 26% Below Its Share Price - Yahoo Finance
生命科学资讯
生物技术与制药领域的最新动态
埃文斯加时赛建功，橡树岭队夺得大都会联盟男子篮球冠军——奥兰多哨兵报
Evans in OT, Oak Ridge claim Metro Conference boys basketball titles - Orlando Sentinel
Synaffix与Sidewinder携手推进新一代双特异性ADC研发——基因工程与生物技术新闻
Synaffix and Sidewinder Agree to Advance Next-Generation Bispecific ADC Development - Genetic Engineering and Biotechnology News
Synaffix与Sidewinder达成协议，共同推进新一代双特异性抗体药物偶联物研发——基因工程与生物技术新闻
Synaffix and Sidewinder Agree to Advance Next-Generation Bispecific ADC Development - Genetic Engineering and Biotechnology News
龙沙Synaffix与Sidewinder合作开发抗体药物偶联物 - 医药快讯
Lonza’s Synaffix and Sidewinder collaborate on ADCs - The Pharma Letter
龙沙Synaffix与Sidewinder合作开发ADC药物 - 医药通讯
Lonza’s Synaffix and Sidewinder collaborate on ADCs - The Pharma Letter
Lonza旗下Synaffix与Sidewinder合作开发双特异性抗体药物偶联物
Lonza’s Synaffix and Sidewinder partner on bispecific ADCs By Investing.com - Investing.com Canada
龙沙集团Synaffix与Sidewinder合作开发双特异性抗体药物偶联物 - Investing.com
Lonza’s Synaffix and Sidewinder partner on bispecific ADCs - Investing.com
龙沙集团Synaffix与Sidewinder Therapeutics签署多靶点许可协议，共同推进下一代双特异性ADC药物研发
Lonza's Synaffix and Sidewinder Therapeutics Announce Multi-Target License Agreement to Advance Development of Next-Generation Bispecific ADCs - Yahoo Finance
龙沙集团股票：悄然反弹，投资者谨慎乐观，权衡生物科技新篇章——特别报道
Lonza Group AG stock: Quiet rebound, cautious optimism as investors weigh biotech’s next chapter - AD HOC NEWS
细胞疗法CDMO市场即将迎来繁荣 |• 龙沙集团 • 药明康德 - openPR.com
Cell Therapy CDMO Market Is Going to Boom |• Lonza • WuXi AppTec - openPR.com
龙沙集团股票：是平静盘整还是为2026年蓄势待发？ - 特别报道
Lonza Group AG stock: quiet consolidation or coiled spring for 2026? - AD HOC NEWS
龙沙集团股票：2026年是平静盘整还是蓄势待发？ - 特别新闻
Lonza Group AG stock: quiet consolidation or coiled spring for 2026? - AD HOC NEWS
龙沙集团（场外交易代码：LZAGY）12月空头兴趣下降28.5%——MarketBeat报道
Lonza Group Ag (OTCMKTS:LZAGY) Short Interest Down 28.5% in December - MarketBeat
龙沙集团期货合约 - TradingView — 追踪所有市场
Futures Contracts for Lonza Group Futures - TradingView — Track All Markets
Lonza集团（VTX:LONN）当前是否存在投资机遇？ - simplywall.st
Is There Now An Opportunity In Lonza Group AG (VTX:LONN)? - simplywall.st
Lonza集团股份（普通股）（LO3A）能否从绿色政策中获益——周度涨幅总结与技术确认提醒——宝莱坞咨询热线
Will Lonza Group AG (Common Stock) (LO3A) stock gain from green policies - Weekly Gains Summary & Technical Confirmation Alerts - Bollywood Helpline
Lonza CHI：面向新一代植物基营养保健品的有机胶囊 - nutritioninsight.com
Lonza CHI: Organic capsules for next-gen plant-based nutraceuticals - nutritioninsight.com
龙沙集团（场外交易代码：LZAGY）交易量异常激增——下一步将如何发展？——MarketBeat
Lonza Group (OTCMKTS:LZAGY) Sees Unusually-High Trading Volume - What's Next? - MarketBeat
龙沙集团、Catalent与Recipharm领跑125亿美元吸入药物合同制造市场 - pharmiweb.com
Lonza Group, Catalent, and Recipharm Lead the $12.5 Billion Inhaled Drugs Contract Manufacturing Mar - pharmiweb.com